VOYA Investment Management
MRVI icon

VOYA Investment Management’s Maravai LifeSciences MRVI Stock Holding History

VOYA Investment Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$138K Buy
22,131
+1,910
+9% +$8.25K ﹤0.01% 2313
2026
Q1 		$57.2K Sell
20,221
-709
-3% -$2.4K ﹤0.01% 2265
2025
Q4 		$68K Hold
20,930
– – ﹤0.01% 2307
2025
Q3 		$60.1K Sell
20,930
-13,846
-40% -$35.4K ﹤0.01% 2368
2025
Q2 		$83.8K Buy
34,776
+3,462
+11% +$7.28K ﹤0.01% 2522
2025
Q1 		$69.2K Sell
31,314
-315,409
-91% -$1.25M ﹤0.01% 2502
2024
Q4 		$1.89M Buy
346,723
+267,485
+338% +$1.72M ﹤0.01% 1321
2024
Q3 		$658K Sell
79,238
-38,193
-33% -$330K ﹤0.01% 1850
2024
Q2 		$841K Sell
117,431
-71,386
-38% -$616K ﹤0.01% 1718
2024
Q1 		$1.64M Buy
188,817
+109,497
+138% +$741K ﹤0.01% 1423
2023
Q4 		$520K Sell
79,320
-957
-1% -$6.18K ﹤0.01% 2057
2023
Q3 		$803K Sell
80,277
-859
-1% -$9.43K ﹤0.01% 1764
2023
Q2 		$1.01M Sell
81,136
-75,080
-48% -$1.01M ﹤0.01% 1661
2023
Q1 		$2.19M Buy
156,216
+4,683
+3% +$67.3K ﹤0.01% 1318
2022
Q4 		$2.17M Buy
151,533
+84,274
+125% +$1.33M ﹤0.01% 1288
2022
Q3 		$1.72M Buy
67,259
+20,243
+43% +$508K ﹤0.01% 1383
2022
Q2 		$1.34M Sell
47,016
-6,397
-12% -$203K ﹤0.01% 1265
2022
Q1 		$1.88M Sell
53,413
-1,009
-2% -$33.8K ﹤0.01% 1141
2021
Q4 		$2.28M Buy
54,422
+21,769
+67% +$882K ﹤0.01% 1102
2021
Q3 		$1.6M Buy
32,653
+7,753
+31% +$378K ﹤0.01% 1291
2021
Q2 		$1.04M Buy
24,900
+6,214
+33% +$241K ﹤0.01% 1600
2021
Q1 		$666K Buy
+18,686
New +$619K ﹤0.01% 1855

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

VOYA Investment Management's MRVI Position: Q2 2026 in Review

VOYA Investment Management increased its Maravai LifeSciences (MRVI) stake by 9.4% in Q2 2026, buying an estimated $8.25K and bringing the position to 22,131 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #2313.

VOYA Investment Management first reported a position in MRVI in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.28M in Q4 2021. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • VOYA Investment Management held 22,131 shares of Maravai LifeSciences worth $138K as of Q2 2026.
  • VOYA Investment Management bought 1,910 Maravai LifeSciences shares in Q2 2026, an estimated $8.25K.
  • Maravai LifeSciences made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2313 holding.
  • VOYA Investment Management first reported a position in Maravai LifeSciences in Q1 2021 and has held it in 22 quarters since.
  • VOYA Investment Management's Maravai LifeSciences position peaked at $2.28M in Q4 2021.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.